These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24492232)

  • 1. [Evaluation of the association between the use of oral anti-hyperglycemic agents and hypoglycemia in Japan by data mining of the Japanese Adverse Drug Event Report (JADER) database].
    Umetsu R; Nishibata Y; Abe J; Suzuki Y; Hara H; Nagasawa H; Kinosada Y; Nakamura M
    Yakugaku Zasshi; 2014; 134(2):299-304. PubMed ID: 24492232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antidiabetic agents in type 2 diabetes.
    Levetan C
    Curr Med Res Opin; 2007 Apr; 23(4):945-52. PubMed ID: 17407651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the sitagliptin alert on prescription of oral antihyperglycemic drugs in Japan.
    Sato D; Sato Y; Masuda S; Kimura H
    Int J Clin Pharm; 2012 Dec; 34(6):917-24. PubMed ID: 22941471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Hypoglycemia After Concomitant Use of Antidiabetic, Antihypertensive, and Antihyperlipidemic Medications: A Database Study.
    Gosho M
    J Clin Pharmacol; 2018 Oct; 58(10):1324-1331. PubMed ID: 29762878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes and oral antihyperglycemic drugs.
    Mizuno CS; Chittiboyina AG; Kurtz TW; Pershadsingh HA; Avery MA
    Curr Med Chem; 2008; 15(1):61-74. PubMed ID: 18220763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus.
    Sun GE; Wells BJ; Yip K; Zimmerman R; Raghavan D; Kattan MW; Kashyap SR
    Diabetes Obes Metab; 2014 Mar; 16(3):276-83. PubMed ID: 24199848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemia Associated with Antibiotics Alone and in Combination with Sulfonylureas and Meglitinides: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS).
    Kennedy KE; Teng C; Patek TM; Frei CR
    Drug Saf; 2020 Apr; 43(4):363-369. PubMed ID: 31863282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
    Fisman EZ; Tenenbaum A; Motro M; Adler Y
    Herz; 2004 May; 29(3):290-8. PubMed ID: 15167955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
    Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database.
    Tanabe M; Motonaga R; Terawaki Y; Nomiyama T; Yanase T
    J Diabetes Investig; 2017 Mar; 8(2):227-234. PubMed ID: 27549920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database.
    Tanabe M; Nomiyama T; Motonaga R; Murase K; Yanase T
    BMC Endocr Disord; 2015 Sep; 15():49. PubMed ID: 26382923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicide attempt by an overdose of sitagliptin, an oral hypoglycemic agent: a case report and a review of the literature.
    Furukawa S; Kumagi T; Miyake T; Ueda T; Niiya T; Nishino K; Murakami S; Murakami M; Matsuura B; Onji M
    Endocr J; 2012; 59(4):329-33. PubMed ID: 22277726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.
    Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T
    Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
    Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
    Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous Pemphigoid and Diabetes medications: A disproportionality analysis based on the FDA Adverse Event Reporting System.
    Huang L; Liu Y; Li H; Huang W; Geng R; Tang Z; Jiang Y
    Int J Med Sci; 2021; 18(9):1946-1952. PubMed ID: 33850463
    [No Abstract]   [Full Text] [Related]  

  • 16. Emergency management of oral hypoglycemic drug toxicity.
    Rowden AK; Fasano CJ
    Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse effects of oral hypoglycemic agents].
    Mori Y; Sekihara H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():325-31. PubMed ID: 12387013
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for adverse symptoms during dipeptidyl peptidase-IV inhibitor therapy: a questionnaire-based study carried out by the Japan Pharmaceutical Association Drug Event Monitoring project in Kumamoto Prefecture.
    Kajiwara A; Saruwatari J; Sakata M; Morita K; Kita A; Oniki K; Yamamura M; Murase M; Koda H; Hirota S; Ishizuka T; Nakagawa K
    Drug Saf; 2013 Oct; 36(10):981-7. PubMed ID: 23743694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypoglycemia in the diabetes treatment - risk minimization with dipeptidyl peptidase-4 inhibitors].
    Acuña C
    Drugs Today (Barc); 2010 Dec; 46 Suppl F():1-12. PubMed ID: 21240332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Spontaneous Reporting Systems to Detect Host-Medication Interactions: Sex Differences in Oral Anti-Diabetic Drug-Associated Myocardial Infarction.
    Wang SH; Chen WJ; Hsu LY; Chien KL; Wu CS
    J Am Heart Assoc; 2018 Nov; 7(22):e008959. PubMed ID: 30571494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.